🇺🇸 FDA
Patent

US 7348335

Compositions useful as inhibitors of JAK and other protein kinases

granted A61PA61P1/16A61P11/00

Quick answer

US patent 7348335 (Compositions useful as inhibitors of JAK and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/16, A61P11/00, A61P11/06, A61P19/02